National Institute on Drug Abuse (NIDA): all 393 studies

Page 2 of 4. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• fMRI Study of Nicotinic Effect on Neurophysiology of SchizophreniaCompletedNCT01046526
• PET Imaging of Nicotinic Acetylcholine ReceptorsCompletedNCT01046513
• Antagonist-Elicited Cannabis WithdrawalCompletedNCT01041170Phase 1
• Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational SmokersCompletedNCT01038245
• Measuring Distress Tolerance With Functional MRICompletedNCT01038232
• Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain ActivationCompletedNCT01037608Phase 1
• Optimizing Toxicological Screening in Drug Endangered ChildrenCompletedNCT01037569
• Effects of Nicotine on Brain Activity as Measured by fMRICompletedNCT01037153
• Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug DependenceCompletedNCT01037075
• Screening Protocol for the Evaluation of Potential Research SubjectsCompletedNCT01036971
• Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRICompletedNCT01036711
• Cognitive Task Development and Implementation for Functional MRI StudiesCompletedNCT01036685
• Neuroimaging Studies of Neurophysiological Phenotypes in SchizophreniaCompletedNCT01036568
• PET Assays of Striatal Dopamine Marker in Cocaine CravingCompletedNCT01036516
• The Effects of Expectation on Natural and Drug -Induced RewardsCompletedNCT01036230
• Screening Protocol for the Evaluation of Research ParticipantsCompletedNCT01036217
• Automatic Versus Evaluative Components of Cue ReactivityCompletedNCT01036126
• Reward Processing in Cocaine AddictionCompletedNCT01036074
• Dopamine Function and Reward Processing In SchizophreniaCompletedNCT01035996
• Effect of Functional Genetic Polymorphisms on Brain Morphology and FunctionCompletedNCT01035723
• Study of Smoking AbstinenceCompletedNCT01035632
• The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215CompletedNCT01034800
• Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco AbstinenceCompletedNCT01034384
• Effects of Nicotine on Areas of Impaired and Preserved Functioning in SchizophreniaCompletedNCT01034085
• Effects of Nicotine on Elements of Attentions in Smokers and NonsmokersCompletedNCT01034020Phase 1
• Pilot Study of Transcranial Magnetic Stimulation (TMS) in Nicotine AddictionCompletedNCT01031693Phase 1
• Risk Perception in Drug-Dependent Adults With and Without SchizophreniaCompletedNCT01031563
• Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual RealityCompletedNCT01031433
• Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis CravingWithdrawnNCT01031290Phase 1
• Breath Carbon Monoxide and Cotinine as Biomarkers to Distinguish Smokers From NonsmokersCompletedNCT01031121
• Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)CompletedNCT01030835
• Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior DevelopmentCompletedNCT01020669
• Brain Glutamate Receptors and Cocaine DependenceTerminatedNCT00951314
• Physician Focused Intervention to Improve Adherence With HIV AntiretroviralsCompletedNCT00870792Not applicable
• Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic CorrelatesWithdrawnNCT00865332
• An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug UsersCompletedNCT00841477Phase 3
• A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive ControlCompletedNCT00830739
• Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment PopulationCompletedNCT00787423
• Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance PatientsCompletedNCT00780702Phase 1
• Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal NicotineCompletedNCT00777569Phase 2
• Buprenorphine Naltrexone-P1 A-CocaineCompletedNCT00733720Phase 1
• Cognitive Behavioral Stress Management for HIV+ Drug AbusersCompletedNCT00722644Phase 1
• Effects of Propranolol on Responses to Drug-Related Imagery ScriptsTerminatedNCT00688805Phase 1
• Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug AbusersCompletedNCT00685620Phase 4
• Vigabatrin Ph 1 Cocaine Interaction StudyCompletedNCT00626834Phase 1
• Effects of Smoking on Opioid Receptor Binding: A PET StudyCompletedNCT00618631Phase 1
• Sublingual Buprenorphine for Chronic PainStatus unknownNCT00612287Phase 2
• Integration of the Therapeutic Workplace in Drug CourtCompletedNCT00607360Phase 1
• Chronic Hepatitis Intervention Project for Drug UsersCompletedNCT00596843Phase 3
• A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective DisorderCompletedNCT00593099Phase 1/2
• A Timeline Study of Alcohol Use and Its Relationship to InsomniaCompletedNCT00580411
• Motivation and Patch Treatment for HIV-positive SmokersCompletedNCT00551720Phase 3
• Preventing Substance Use and Risky Behavior Among Rural African American YouthCompletedNCT00535704Not applicable
• Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1Status unknownNCT00519259Phase 1
• Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence SyndromeCompletedNCT00510016Phase 2
• Reduction of Smoking in Cardiac Disease PatientsCompletedNCT00469885Phase 2
• Student Athlete Testing Using Random NotificationCompletedNCT00451854Not applicable
• Metabolic Effects of CocaineCompletedNCT00451230Not applicable
• Positive Choice: Prevention for Positive HealthCompletedNCT00447707Not applicable
• Ph1 Lobeline Interaction Study - 1Status unknownNCT00439504Phase 1
• Ph1 Marinol Interaction Study - Part 1 - 1TerminatedNCT00438139Phase 1
• Human Factors Analysis in VR for Burn TreatmentCompletedNCT00409552Phase 1/2
• Study to Reduce Intravenous Exposures (STRIVE)CompletedNCT00391482Phase 2/3
• Hyperalgesia in Methadone Patients: Can it be Treated?Status unknownNCT00333242Phase 1
• Randomized Trial of the Positive Action Program in Hawaii SchoolsCompletedNCT00328445Not applicable
• Effects of Buspirone in Opiate WithdrawalCompletedNCT00326235Phase 4
• Effect of Clonidine on Responses to Imagery ScriptsCompletedNCT00318760Phase 1
• Efficacy of NicVAX in Smokers Who Want to Quit SmokingCompletedNCT00318383Phase 2
• Effects of Fatty Acid Supplementation on Substance Dependent IndividualsCompletedNCT00312455Phase 2
• Drug Use Prevention Among Girls Through a Mother-Daughter InterventionCompletedNCT00310258Phase 3
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who SmokeCompletedNCT00307203Phase 4
• Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved ParoleesStatus unknownNCT00302575Not applicable
• Implementing Tobacco Control in Dental PracticeStatus unknownNCT00297700Phase 3
• Serotonin, Impulsivity, and Cocaine Dependence TreatmentCompletedNCT00297505Phase 2
• Strategies to Help Adult ED Patients Quit SmokingCompletedNCT00297466Not applicable
• Clonidine for Relapse Prevention in Buprenorphine-Maintenance PatientsCompletedNCT00295308Phase 1
• Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility StudyCompletedNCT00292136
• Combined Behavioral and Pharmacologic Treatment of Polydrug AbuseCompletedNCT00292123Phase 1
• Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency ManagementCompletedNCT00292110Phase 1
• Smoking and Alcohol InitiationCompletedNCT00271843
• A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Status unknownNCT00267657Phase 1
• Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Status unknownNCT00265278Phase 1
• Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1CompletedNCT00265265Phase 1
• Emergency Department Initiated Tobacco Treatment (EDITT)CompletedNCT00252902Phase 1/2
• Contingency Management for Attendance - 2CompletedNCT00249639Not applicable
• Medication Adherence Therapy for Opioid Abusing Pain PatientsCompletedNCT00249587Phase 1/2
• Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
• Low-Cost Contingency Management for Hispanic Outpatients - 3CompletedNCT00249548Not applicable
• Vouchers vs. Prizes for Methadone Patients - 1CompletedNCT00249522Not applicable
• Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent IndividualsCompletedNCT00249509Phase 2
• Efficacy and Safety of Bupropion for Treatment of Adolescent SmokingTerminatedNCT00248118Phase 2/3
• The Genetic Basis for Vulnerability to Substance AbuseCompletedNCT00247819
• Methylphenidate Studies for Drug Abuse Vulnerability Molecular GenenticsTerminatedNCT00247689
• Examining the Role of Negative Emotional States on Sedative Drug Use in Individuals With Post-Traumatic Stress DisorderCompletedNCT00244335
• Modifying Group Therapy for Bipolar Substance Abusers - 1CompletedNCT00227838Not applicable
• The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1Status unknownNCT00227825Phase 2
• Integrated Treatment for Cocaine and Mood Disorders - 1CompletedNCT00227812Phase 2
• Early Tobacco Abstinence - 5TerminatedNCT00224965Phase 1
• Effectiveness of Self-Help for Dually-Diagnosed Persons - 1CompletedNCT00218582Phase 1/2
• Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1CompletedNCT00218556Not applicable

← National Institute on Drug Abuse (NIDA) overview and focus areas